The Phase III FIND-CKD trial demonstrated that finerenone (Kerendiaâ„¢), when added to standard care, significantly reduced the rate of kidney function decline in adults with non-diabetic ...
Dr Amir Khan said there has been a big increase in patients getting the condition ...
41-year-old Chris Wall collapsed during a workout class ...